On November 1, 2024, CMS issued a rule finalizing changes to Medicare payments under the Physician Fee Schedule (PFS) and other Medicare Part B policies effective on or after January 1, 2025 (the Final Rule). Section 1848 of...more
11/20/2024
/ Biosimilars ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances ,
Final Rules ,
Food and Drug Administration (FDA) ,
FQHC ,
HCPCS ,
Health Care Providers ,
Inflation Reduction Act (IRA) ,
Infrastructure Investment and Jobs Act (IIJA) ,
MACs ,
Medicare ,
Medicare Part B ,
Mental Health ,
New Legislation ,
Opioid ,
Physician Fee Schedule ,
Popular ,
Prescription Drugs ,
Public Health Emergency ,
Risk Assessment ,
Risk Management ,
Rural Health Care Providers ,
Social Security Act ,
Substance Abuse ,
Telecommunications ,
Telehealth ,
Vaccinations
Over the past 16 months, three of the nation’s largest commercial payers – UnitedHealthcare, Anthem and CIGNA – have instituted new policies affecting how and whether they will pay for high-cost drugs administered in hospital...more
President Trump signed the Families First Coronavirus Response Act, H.R. 6201, on March 18th, 2020 after it passed in the Senate without amendment. The Act, Public Law 116-127, has become known as “Phase II” of the...more